Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

WHO's Tedros Says Uganda Should Reconsider Congo Border Closure Over Ebola

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

AI Brings Oxygen Therapy Closer to Autopilot

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

Ontario Researchers Discover Promising Antibiotic

McMaster University researchers have discovered a new antibiotic that kills drug-resistant bacteria through a previously unrecognized mechanism of action.

Lyme Primer: How the HHS Strategy Stacks Up To Science

Experts support targeting ticks but caution against the long-term use of antibiotics.

TNFi Use in Early Peripheral SpA Outperforms Methotrexate

‘These data [from the phase 3 SPARTACUS trial] support the importance of early diagnosis and early treatment before structural damage,’ said one expert not involved in the research.

FDA Approves First New Sunscreen Option in Two Decades

Bemotrizinol protects against both ultraviolet A and B rays, has low absorption through the skin, and is safe for adults and children 6 months and older, according to the FDA.

Todays Updates

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Todays Updates

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Latest News

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

McMaster University researchers have discovered a new antibiotic that kills drug-resistant bacteria through a previously unrecognized mechanism of action.

Experts support targeting ticks but caution against the long-term use of antibiotics.

‘These data [from the phase 3 SPARTACUS trial] support the importance of early diagnosis and early treatment before structural damage,’ said one expert not involved in the research.

Bemotrizinol protects against both ultraviolet A and B rays, has low absorption through the skin, and is safe for adults and children 6 months and older, according to the FDA.

News All Time

SARS-CoV-2 Poses Greater Autoimmune Risk Than Vaccines

Spanish dermatologists report that vaccine-related skin eruptions are uncommon, while SARS-CoV-2 infection itself is more strongly linked to autoimmune and vascular complications.

When Your Loved Ones Trust TikTok Over Their Doctor — & You

Physicians recount how health disinformation damaged close relationships and forced them to rethink how to advise loved ones.

Bimekizumab Trumps Risankizumab in Head-to-Head PsA Trial

Dual IL-17A/F inhibition was superior to IL-23 inhibition for managing joint involvement in psoriatic arthritis, according to findings from the phase 3b BE BOLD study.

Professional Corner: Groups Decry Medicaid Work Requirement

Societies say a federal policy may reduce access to care. The American Academy of Pediatrics updates its guidance on generic drugs. And a new research network focuses on heart transplant outcomes.

Why Cosmetic Surgery Abroad Can Backfire

Lower prices are drawing patients abroad for cosmetic surgery, but variable surgical expertise, limited follow-up care, and serious postoperative complications can quickly erase the savings.

Mepolizumab Boosts Quality of Life in CRSwNP

Mepolizumab improves disease-specific quality of life, reduces polyp burden, and improves asthma control in patients with severe chronic rhinosinusitis with nasal polyps, a real-world study shows.

Early Eosinophil Counts Affect Asthma in Pregnancy

Periconception levels show potential as a clinically useful marker for patients at risk.

MHRA Begins Review of Avacopan for Autoimmune Vasculitis

The UK’s drugs regulator is reviewing the integrity of trial data underpinning avacopan's licence for ANCA-associated vasculitis.

Ruto Says US Plan to Build Ebola Facility in Kenya Is the 'right Thing'

Kenyan President William Ruto on Thursday said his government was doing "the right thing" by allowing the United States to set up an Ebola quarantine facility ⁠in...

US Domestic Treatment Centers Ready for Ebola Even as Kenya Plans Persist

Most of the 13 U.S. treatment centers in a government-funded hospital network for severe infectious diseases are ready to handle patients, including those with Ebola if...

Otsuka Says Kidney Disease Drug Preserves Function in Late-stage Study

Otsuka Pharmaceutical said on Thursday its drug in a late-stage study preserved kidney ⁠function over 12 months in patients with a type of autoimmune disease that affects...

How Doctors’ Regrets Evolve — and What to Do With Yours

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Obexelimab Lowers Flare Risk in Phase 3 IgG4-RD Trial

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic steroid exposure in patients with active IgG4-related disease.

Anifrolumab Improves Multiple Sjögren Disease Measures

Early data from the ANISE-II study show that the lupus-approved treatment may also work well in managing Sjögren disease.

JAK1 Inhibitor Zemprocitinib Hits Targets in Refractory RA

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Infection Risk in Lupus and RA: What Matters Most

Disease activity, organ involvement, and treatment choice all shape infection risk in lupus and rheumatoid arthritis, with new data highlighting where clinicians should focus.

Recommended News For You

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

Screening for prostate cancer: is it time to give up digital rectal examination?

Effective Intralesional Melanoma Therapy May Involve Systemic Effects.

Black and Hispanic children with high-risk neuroblastoma have worse outcomes despite standardized treatment

Minimally invasive prostate cancer treatment shows success in first patient

Universal screening approach achieves a comparable detection rate of lung cancer

Recommended Articles For You

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care 

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment 

The Importance of Having a Quick and Effective Heparin Antidote  

A Visual Guide to Understanding Breast Cancer Staging 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

2.

AI-based liquid biopsy shows promise for detecting brain cancer

3.

Using MRD Status to Deescalate Multiple Myeloma Therapy

4.

A study on lung cancer provides additional proof of the value of screening.

5.

Can taking vitamin D supplements every day lower the mortality rate from cancer?

1.

The Danger of Methemoglobinemia and How to Prevent It 

2.

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer

3.

A Closer Look at the Effects of Sickle Cell on Eyesight

4.

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era

5.

The Role of Calcium Corrections in Accurate Blood Test Results 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

3.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot